F2L, a peptide derived from heme-binding protein, inhibits LL-37-induced cell proliferation and tube formation in human umbilical vein endothelial cells
SCIE
SCOPUS
- Title
- F2L, a peptide derived from heme-binding protein, inhibits LL-37-induced cell proliferation and tube formation in human umbilical vein endothelial cells
- Authors
- Lee, SY; Lee, MS; Lee, HY; Kim, SD; Shim, JW; Jo, SH; Lee, JW; Kim, JY; Choi, YW; Baek, SH; Ryu, SH; Bae, YS
- Date Issued
- 2008-01
- Publisher
- ELSEVIER SCIENCE BV
- Abstract
- F2L, a peptide derived from heme-binding protein, was originally identified as an endogenous ligand for formyl peptide receptor-like (FPRL)2. Previously, we reported that F2L inhibits FPR and FPRL1-mediated signaling in neutrophils. Since endothelial cells express functional FPRL1, we examined the effect of F2L on LL-37 (an FPRL1 agonist)-induced signaling in human umbilical vein endothelial cells (HUVECs). F2L stimulated the chemotactic migration in HUVECs. However, F2L inhibited FPRL1 activity, resulting in the inhibition of cell proliferation and tube formation induced by LL-37 in HUVECs. We suggest that F2L will potentially be useful in the study of FPRL1 signaling and the development of drugs to treat diseases involving the FPRL1 in the vascular system. (C) 2007 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
- Keywords
- F2L; formyl peptide receptor-like 1; chemotaxis; angiogenesis; cell proliferation; endothelial cell; SPHINGOSINE 1-PHOSPHATE; NATURAL ANTAGONIST; LYSOPHOSPHATIDIC ACID; HUMAN MONOCYTES; IN-VITRO; ANGIOGENESIS; RECEPTORS; IDENTIFICATION; LL-37; INVOLVEMENT
- URI
- https://oasis.postech.ac.kr/handle/2014.oak/22670
- DOI
- 10.1016/j.febslet.2007.12.015
- ISSN
- 0014-5793
- Article Type
- Article
- Citation
- FEBS LETTERS, vol. 582, no. 2, page. 273 - 278, 2008-01
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.